Tribenoside
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| ethyl 3,5,6-tri-O-benzyl-D-glucofuranoside | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 10310-32-4  |
| ATC code | C05AX05 C05CX01 |
| PubChem | CID 25145 |
| UNII | Z7N0Y673NU  |
| ChEMBL | CHEMBL1446743 |
| Synonyms | (3R,4R,5R)-4-(benzyloxy)-5-[1,2-bis(benzyloxy)ethyl]-2-ethoxyoxolan-3-ol |
| Chemical data | |
| Formula | C29H34O6 |
| Mol. mass | 478.57666 g/mol |
 (what is this?) (verify) |
|
Tribenoside is a vasoprotective and a mixture of the α- und β-anomers.
Induction of hypersensitivity has been reported.[1]
[edit] References
- ^ Hashizume H, Takigawa M (2005). "Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells". Acta Derm. Venereol. 85 (1): 47–50. doi:10.1080/00015550410024094. PMID 15848991. http://adv.medicaljournals.se/article/full/10.1080/00015550410024094.
|
||||||||||||||||
 |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
